Standard Chemical & Pharmaceutical Co Ltd (1720) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Standard Chemical & Pharmaceutical Co Ltd (1720) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$510.55 Million ≈ $16.09 Million USD) by net assets (NT$9.02 Billion ≈ $284.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Standard Chemical & Pharmaceutical Co Lt (1720) market capitalisation for the company's overall valuation and market capitalisation.
Standard Chemical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Standard Chemical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Standard Chemical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Standard Chemical & Pharmaceutical Co Lt (1720) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Radium Life Tech Co Ltd
TW:2547
|
0.025x |
|
Harbin VITI Electronics Corp
SHG:603023
|
-0.020x |
|
StealthGas Inc
F:S6W
|
0.024x |
|
Izmir Demir Celik Sanayi AS
IS:IZMDC
|
-0.021x |
|
DITTO (THAILAND)
BK:DITTO-R
|
-0.028x |
|
Galan Lithium Ltd
AU:GLN
|
-0.008x |
|
Global Indemnity Group, LLC Class A Common Stock
NASDAQ:GBLI
|
0.000x |
|
Putnam Premier Income Trust
NYSE:PPT
|
N/A |
Annual Cash Flow Conversion Efficiency for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. View latest Standard Chemical & Pharmaceutical Co Lt stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$8.98 Billion ≈ $282.80 Million |
NT$1.69 Billion ≈ $53.40 Million |
0.189x | +14.97% |
| 2023-12-31 | NT$8.14 Billion ≈ $256.37 Million |
NT$1.34 Billion ≈ $42.11 Million |
0.164x | -0.53% |
| 2022-12-31 | NT$7.44 Billion ≈ $234.26 Million |
NT$1.23 Billion ≈ $38.68 Million |
0.165x | +35.76% |
| 2021-12-31 | NT$6.80 Billion ≈ $214.23 Million |
NT$827.03 Million ≈ $26.06 Million |
0.122x | -35.32% |
| 2020-12-31 | NT$4.91 Billion ≈ $154.56 Million |
NT$922.58 Million ≈ $29.07 Million |
0.188x | +36.97% |
| 2019-12-31 | NT$4.65 Billion ≈ $146.39 Million |
NT$637.94 Million ≈ $20.10 Million |
0.137x | +20.22% |
| 2018-12-31 | NT$4.25 Billion ≈ $133.78 Million |
NT$484.94 Million ≈ $15.28 Million |
0.114x | -32.29% |
| 2017-12-31 | NT$4.20 Billion ≈ $132.39 Million |
NT$708.74 Million ≈ $22.33 Million |
0.169x | +131.78% |
| 2016-12-31 | NT$4.20 Billion ≈ $132.22 Million |
NT$305.38 Million ≈ $9.62 Million |
0.073x | -56.54% |
| 2015-12-31 | NT$3.89 Billion ≈ $122.46 Million |
NT$650.87 Million ≈ $20.51 Million |
0.167x | +3.69% |
| 2014-12-31 | NT$3.61 Billion ≈ $113.60 Million |
NT$582.30 Million ≈ $18.35 Million |
0.161x | +35.41% |
| 2013-12-31 | NT$3.58 Billion ≈ $112.87 Million |
NT$427.26 Million ≈ $13.46 Million |
0.119x | -1.97% |
| 2012-12-31 | NT$3.31 Billion ≈ $104.17 Million |
NT$402.25 Million ≈ $12.67 Million |
0.122x | -6.33% |
| 2011-12-31 | NT$3.12 Billion ≈ $98.36 Million |
NT$405.49 Million ≈ $12.78 Million |
0.130x | +38.92% |
| 2010-12-31 | NT$2.91 Billion ≈ $91.81 Million |
NT$272.47 Million ≈ $8.58 Million |
0.094x | -58.59% |
| 2009-12-31 | NT$2.81 Billion ≈ $88.50 Million |
NT$634.23 Million ≈ $19.98 Million |
0.226x | -18.22% |
| 2008-12-31 | NT$2.60 Billion ≈ $82.07 Million |
NT$719.17 Million ≈ $22.66 Million |
0.276x | +119.99% |
| 2007-12-31 | NT$2.58 Billion ≈ $81.23 Million |
NT$323.60 Million ≈ $10.20 Million |
0.126x | -9.88% |
| 2006-12-31 | NT$2.58 Billion ≈ $81.17 Million |
NT$358.75 Million ≈ $11.30 Million |
0.139x | -9.29% |
| 2005-12-31 | NT$2.42 Billion ≈ $76.09 Million |
NT$370.77 Million ≈ $11.68 Million |
0.154x | -17.69% |
| 2004-12-31 | NT$1.80 Billion ≈ $56.67 Million |
NT$335.45 Million ≈ $10.57 Million |
0.187x | +13.25% |
| 2003-12-31 | NT$1.66 Billion ≈ $52.21 Million |
NT$272.89 Million ≈ $8.60 Million |
0.165x | +75.71% |
| 2002-12-31 | NT$1.58 Billion ≈ $49.67 Million |
NT$147.75 Million ≈ $4.66 Million |
0.094x | -- |
About Standard Chemical & Pharmaceutical Co Ltd
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more